TSE:4523Pharmaceuticals
Eisai (TSE:4523) Profit Soars 54%—Earnings Turnaround Reinforces Bullish Narrative
Eisai (TSE:4523) delivered a striking turnaround in its latest earnings report, with profits jumping 54.1% over the past year after having declined at an annualized rate of 14.1% for five years straight. Net profit margin climbed from 4.4% to 6.3% year on year, and the company now projects earnings growth of 13.7% annually, well ahead of the broader Japanese market forecast of 7.9% per year. Revenue is expected to grow slightly below the market rate at 4.1% per year. Despite the premium...